Hamilton Lane (NASDAQ:HLNE) Stock Price Expected to Rise, Keefe, Bruyette & Woods Analyst Says

Hamilton Lane (NASDAQ:HLNE - Get Free Report) had its price target increased by equities research analysts at Keefe, Bruyette & Woods from $158.00 to $168.00 in a research note issued on Wednesday,Benzinga reports. The brokerage presently has a "market perform" rating on the stock. Keefe, Bruyette & Woods' price target would indicate a potential upside of 0.48% from the company's previous close.

Other analysts have also issued research reports about the stock. Wells Fargo & Company lifted their price objective on shares of Hamilton Lane from $163.00 to $169.00 and gave the stock an "equal weight" rating in a research report on Wednesday. The Goldman Sachs Group cut shares of Hamilton Lane from a "neutral" rating to a "sell" rating and set a $139.00 price target on the stock. in a research note on Monday, January 6th. Oppenheimer upgraded Hamilton Lane from a "market perform" rating to an "outperform" rating and set a $186.00 target price for the company in a research note on Tuesday, January 21st. Morgan Stanley boosted their price target on shares of Hamilton Lane from $182.00 to $190.00 and gave the company an "equal weight" rating in a research report on Monday, November 11th. Finally, UBS Group upped their price objective on shares of Hamilton Lane from $150.00 to $185.00 and gave the stock a "neutral" rating in a research report on Tuesday, October 22nd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $173.14.

Hamilton Lane Stock Performance

Shares of HLNE stock traded up $0.36 during trading on Wednesday, hitting $167.19. The company's stock had a trading volume of 445,072 shares, compared to its average volume of 419,488. The company has a current ratio of 4.19, a quick ratio of 3.37 and a debt-to-equity ratio of 0.34. The company has a market cap of $9.27 billion, a PE ratio of 30.85 and a beta of 1.25. The business has a fifty day moving average of $159.05 and a 200-day moving average of $163.14. Hamilton Lane has a 52 week low of $103.42 and a 52 week high of $203.72.

Hamilton Lane (NASDAQ:HLNE - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported $1.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. The firm had revenue of $168.26 million during the quarter, compared to the consensus estimate of $158.86 million. Hamilton Lane had a return on equity of 36.69% and a net margin of 31.12%. The business's revenue for the quarter was up 34.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.71 EPS. As a group, research analysts anticipate that Hamilton Lane will post 4.97 earnings per share for the current year.

Institutional Trading of Hamilton Lane

A number of institutional investors have recently made changes to their positions in HLNE. CWM LLC boosted its position in Hamilton Lane by 24.7% during the 3rd quarter. CWM LLC now owns 505 shares of the company's stock valued at $85,000 after buying an additional 100 shares during the period. GAMMA Investing LLC boosted its holdings in shares of Hamilton Lane by 32.4% during the third quarter. GAMMA Investing LLC now owns 637 shares of the company's stock worth $107,000 after purchasing an additional 156 shares during the period. Icon Wealth Advisors LLC bought a new stake in shares of Hamilton Lane in the third quarter worth about $111,000. Harvest Fund Management Co. Ltd purchased a new position in Hamilton Lane during the 3rd quarter valued at about $127,000. Finally, KBC Group NV raised its position in Hamilton Lane by 18.0% during the 3rd quarter. KBC Group NV now owns 1,141 shares of the company's stock valued at $192,000 after purchasing an additional 174 shares during the last quarter. Hedge funds and other institutional investors own 97.40% of the company's stock.

About Hamilton Lane

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.